GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » Other Stockholders Equity

Pharmesis International (SGX:BFK) Other Stockholders Equity : S$-0.25 Mil (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Pharmesis International Other Stockholders Equity?

Pharmesis International's Other Stockholders Equity for the quarter that ended in Dec. 2024 was S$-0.25 Mil.

Pharmesis International's quarterly Other Stockholders Equity increased from Dec. 2023 (S$0.28 Mil) to Jun. 2024 (S$0.28 Mil) but then declined from Jun. 2024 (S$0.28 Mil) to Dec. 2024 (S$-0.25 Mil).

Pharmesis International's annual Other Stockholders Equity declined from Dec. 2022 (S$0.29 Mil) to Dec. 2023 (S$0.28 Mil) and declined from Dec. 2023 (S$0.28 Mil) to Dec. 2024 (S$-0.25 Mil).

Pharmesis International Other Stockholders Equity Historical Data

The historical data trend for Pharmesis International's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmesis International Other Stockholders Equity Chart

Pharmesis International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.32 0.29 0.28 -0.25

Pharmesis International Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.28 0.28 0.28 -0.25

Pharmesis International Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Pharmesis International Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Pharmesis International's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmesis International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmesis International Ltd (SGX:BFK) » Definitions » Other Stockholders Equity
Comparable Companies
SGX:42C ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692 SZSE:000538 BOM:500087 ITCI VTRS TSE:4507 NBIX NSE:TORNTPHARM SHSE:688506 BOM:543904
Traded in Other Exchanges
N/A
Address
5 Kallang Sector, No. 03-02, Singapore, SGP, 349279
Website
https://www.pharmesis.com
Pharmesis International Ltd is an investment holding company. The company manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its operating segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM-formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.